Research Topics
| Anna RingborgSummaryAffiliation: Stockholm Health Economics Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention: a Swedish analysis of the CREDO trialAnna Ringborg
Stockholm Health Economics, Stockholm, Sweden
Eur J Health Econ 6:354-6, 358-62. 2005..Thus the predicted cost-effectiveness ratio of long-term treatment with clopidogrel in patients undergoing PCI is well below the threshold values currently considered cost-effective...
Preterm birth in Sweden: what are the average lengths of hospital stay and the associated inpatient costs?Anna Ringborg
Stockholm Health Economics, Stockholm, Sweden
Acta Paediatr 95:1550-5. 2006....
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillationAnna Ringborg
Europace 10:403-11. 2008..To estimate costs of admission and costs incurred on an annual basis by patients with atrial fibrillation (AF) in Greece, Italy, Poland, Spain, and the Netherlands...
Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register dataA Ringborg
i3 Innovus, Stockholm, Sweden
Int J Clin Pract 62:708-16. 2008..To examine medical resource use of Swedish patients with type 2 diabetes during 2000-2004 and to estimate annual costs of care...
The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in SwedenAnna Ringborg
i3 Innovus, Karolinska Institute, Stockholm, Sweden
Eur J Cardiovasc Prev Rehabil 16:576-82. 2009..The aim of this study was to determine the health care costs associated with acute myocardial infarction (AMI) and stroke in patients with type 2 diabetes in Sweden...
Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countriesEmy Holstenson
i3 Innovus, Klarabergsviadukten 90, Hus D 111 64 Stockholm, Sweden
Europace 13:23-30. 2011....
